KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $27.3 million.

  • Bio-Rad Laboratories' Shares Outstanding (Weighted Average) fell 337.07% to $27.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.3 million, marking a year-over-year decrease of 337.07%. This contributed to the annual value of $27.3 million for FY2025, which is 337.07% down from last year.
  • According to the latest figures from Q4 2025, Bio-Rad Laboratories' Shares Outstanding (Weighted Average) is $27.3 million, which was down 337.07% from $27.4 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Shares Outstanding (Weighted Average) registered a high of $29.9 million during Q1 2022, and its lowest value of $27.3 million during Q4 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $29.4 million (2023), whereas its average is $29.0 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 36.88% in 2022, then tumbled by 364.24% in 2024.
  • Bio-Rad Laboratories' Shares Outstanding (Weighted Average) (Quarter) stood at $29.8 million in 2021, then decreased by 0.15% to $29.8 million in 2022, then decreased by 1.93% to $29.2 million in 2023, then dropped by 3.41% to $28.2 million in 2024, then decreased by 3.37% to $27.3 million in 2025.
  • Its last three reported values are $27.3 million in Q4 2025, $27.4 million for Q3 2025, and $27.6 million during Q2 2025.